Biohaven Stock (NYSE:BHVN)
Previous Close
$13.50
52W Range
$12.97 - $55.70
50D Avg
$14.86
200D Avg
$31.14
Market Cap
$1.33B
Avg Vol (3M)
$2.00M
Beta
3.50
Div Yield
-
BHVN Company Profile
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.